CLASSYS

214150· KOSDAQ· Health Care· Health Care Equipment & Services

₩27,200-2.33%

2026-10-15

Financials

Valuation Metrics

CLASSYS's Market Cap is ₩1.8T. At end of 2025 it was ₩3.6T. Ranked #217 of 2,414 in KR market (top 9%), #45 of 1,633 on KOSDAQ (top 3%), #3 of 94 in Health Care Equipment & Services (top 3%) by Market Cap.

Investment Metrics(as of 2026-10-15)

Metric	Value	Rank
Size
Market Cap	1.77T KRW	KR#217/2,414 Sec#3/94
Revenue	369.11B KRW	KR#748/2,414 Sec#6/94
Net Income	134.45B KRW	KR#203/2,414 Sec#2/94
Total Assets	774.74B KRW	KR#567/2,414 Sec#7/94
Net Assets	555.10B KRW	KR#476/2,414 Sec#6/94
Employees	527	KR#474/2,414 Sec#8/94
Value
P/E	13.20x	KR#1,013/2,414 Sec#30/94
P/B	3.20x	KR#2,156/2,414 Sec#78/94
PEG	0.40x	KR#681/2,414 Sec#26/94
P/S	4.81x	KR#2,143/2,414 Sec#72/94
EV/EBITDA	10.84x	KR#689/2,414 Sec#24/94
FCF Yield	8.51%	KR#685/2,414 Sec#16/94
Profitability
ROE	24.22%	KR#110/2,414 Sec#4/94
ROA	17.35%	KR#75/2,414 Sec#4/94
Op. Margin	46.04%	KR#15/2,414 Sec#1/94
Revenue Growth	25.46%	KR#447/2,414 Sec#23/94
Earnings Growth	32.59%	KR#633/2,414 Sec#28/94
Financial Health
Debt Ratio	39.57%	KR#780/2,414 Sec#39/94
Total Debt	146.66B KRW	KR#610/2,414 Sec#11/94
FCF	151.07B KRW	KR#139/2,414 Sec#2/94
Cash	78.70B KRW	KR#554/2,414 Sec#7/94
Current Ratio	1.60x	KR#1,116/2,414 Sec#63/94
Net Debt/EBITDA	0.40x	KR#654/2,414 Sec#26/94
Dividend
Div. Yield	3.67%	KR#528/2,414 Sec#7/94
Div. Growth	289.11%	KR#33/2,414 Sec#1/94
Performance
1Y Return	-41.88%	KR#1,813/2,414 Sec#60/94
1M Return	-13.92%	KR#1,859/2,414 Sec#76/94
From 52W High	-64.95%	KR#1,919/2,414 Sec#70/94
1Y MDD	-64.02%	KR#1,687/2,414 Sec#58/94
Trading
Volume	202,018 shares	KR#584/2,414 Sec#20/94
Trading Value	5.47B KRW	KR#365/2,414 Sec#9/94
Foreign Own.	68.29%	KR#8/2,414 Sec#1/94
Per Share
EPS	2,061 KRW	KR#444/2,414 Sec#10/94
BPS	8,509 KRW	KR#1,100/2,414 Sec#25/94

Company Info

CEO Choi Yoon-seok

Employees 527

Founded 2015

HQ 서울특별시 강남구, KR

Website classys.co.kr

Classys, established in 2007 and KOSDAQ-listed in 2017, completed the absorptive merger of Iruda Co., Ltd. in 2024. The company specializes in aesthetic medical devices, offering EBD products like HIFU, MRF, MNRF, and Lasers, with equipment and consumables sold in over 80 countries. Classys leverages its in-house organizational structure to secure technology. It is accelerating overseas market penetration through digital marketing and optimized global distribution networks. Classys is headquartered in Gangnam-gu, Seoul Metropolitan City.